Gatalica, Z., Kuzmova, N., Rose, I., Ulamec, M., Perić Balja, M., Skenderi, F. & Vranic, S. (2024). The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status. Biomolecules and Biomedicine, 24. (2), 256-261. doi: 10.17305/bb.2023.9868
Gatalica, Zoran, et al. "The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status." Biomolecules and Biomedicine, vol. 24, no. 2, 2024, pp. 256-261. https://doi.org/10.17305/bb.2023.9868
Gatalica, Zoran, Nataliya Kuzmova, Inga Rose, Monika Ulamec, Melita Perić Balja, Faruk Skenderi and Semir Vranic. "The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status." Biomolecules and Biomedicine 24, no. 2 (2024): 256-261. https://doi.org/10.17305/bb.2023.9868
Gatalica, Z., et al. (2024) 'The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status', Biomolecules and Biomedicine, 24(2), pp. 256-261. doi: 10.17305/bb.2023.9868
Gatalica Z, Kuzmova N, Rose I, Ulamec M, Perić Balja M, Skenderi F, and sur.. The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status. Biomolecules and Biomedicine [Internet]. 2024 March 11 [cited 2024 October 08];24(2):256-261. doi: 10.17305/bb.2023.9868
Z. Gatalica, et al., "The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status", Biomolecules and Biomedicine, vol. 24, no. 2, pp. 256-261, March 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:253311. [Accessed: 08 October 2024]